← Leaderboards
Reza Dastvan
Saint Louis University
$4,521,175
Attributed
$4,521,175
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,521,175 · 3
By mechanism
R37$1,659,998 · 1
S10$1,600,000 · 1
R01$1,261,177 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Physiological”
- Maximilian Haeussler · University Of California Santa Cruz$13,458,813
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Suma Babu · Massachusetts General Hospital$9,298,517
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- James Cappo · National Jewish Health$9,298,220
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
PhysiologicalRegulationResolutionMolecular ConformationProteinsNovel Therapeutic InterventionTherapeutic TargetMalignant NeoplasmsMapsImpairmentMediatingRestraintFlexibilityNeoplasm MetastasisFoundationsElectronsPublic HealthExtracellularStructureInnovationLipidsCryoelectron MicroscopyMembraneMutant
Grant awards (9)
Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer$406,379
R37 · FY2025 · CA · contact PI
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer$392,627
R01 · FY2025 · GM · contact PI
High Q Technologies FATHOM Pulse EPR Spectrometer$1,600,000
S10 · FY2024 · OD · contact PI
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer$395,216
R01 · FY2024 · GM · contact PI
Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer$394,314
R37 · FY2024 · CA · contact PI
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer$65,243
R01 · FY2024 · GM · contact PI
Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer$428,511
R37 · FY2023 · CA · contact PI
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer$408,091
R01 · FY2023 · GM · contact PI
Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer$430,794
R37 · FY2022 · CA · contact PI